Pancreatic Cancer Research

ResearcherUniversity of California, RiversideNo recent work listed

Ahmed F. Salem

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-9640-5836; OpenAlex author ID A5054946644. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents. Co-author DOI 10.3390/ph13050090↗
  2. Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition. Co-author DOI 10.4161/cc.10.21.17895↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maurizio Pellecchia · 1 shared paper, 2020 · strength 0.15
  2. Michael P. Lisanti · 1 shared paper, 2011 · strength 0.03
  3. Hwyda A. Arafat · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.